PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Neuroblastoma D009447 66 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Parkinson Disease D010300 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Peritonitis D010538 38 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Pleurisy D010998 20 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Precancerous Conditions D011230 48 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Respiratory Sounds D012135 3 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Rhinitis D012220 10 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Sarcoidosis D012507 13 associated lipids
Sarcoma 180 D012510 21 associated lipids
Osteosarcoma D012516 50 associated lipids
Seizures D012640 87 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Sneezing D012912 6 associated lipids
Stomach Ulcer D013276 75 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombosis D013927 49 associated lipids
Thyroid Diseases D013959 8 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Translocation, Genetic D014178 20 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Uremia D014511 33 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Urticaria D014581 13 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Wounds, Stab D014951 3 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Reperfusion Injury D015427 65 associated lipids
Weight Loss D015431 56 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
HTLV-I Infections D015490 3 associated lipids
Nasal Obstruction D015508 4 associated lipids
Choroid Diseases D015862 2 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Liver Failure, Acute D017114 11 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Coronavirus Infections D018352 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Endotoxemia D019446 27 associated lipids
Thrombophilia D019851 6 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Stroke D020521 32 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Fetal Weight D020567 12 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Coronary Restenosis D023903 10 associated lipids
Tauopathies D024801 6 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Decapitation D049248 2 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Acute Lung Injury D055371 33 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Airway Remodeling D056151 3 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Drew PD and Chavis JA The cyclopentone prostaglandin 15-deoxy-Delta(12,14) prostaglandin J2 represses nitric oxide, TNF-alpha, and IL-12 production by microglial cells. 2001 J. Neuroimmunol. pmid:11282151
Waits PS et al. Nociceptin/orphanin FQ modulates human T cell function in vitro. 2004 J. Neuroimmunol. pmid:15020071
Diab A et al. Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis. 2004 J. Neuroimmunol. pmid:14975592
Yuhas Y et al. Involvement of prostaglandins in an animal model of Shigella-related seizures. 2005 J. Neuroimmunol. pmid:16139898
Garg TK and Chang JY Methylmercury causes oxidative stress and cytotoxicity in microglia: attenuation by 15-deoxy-delta 12, 14-prostaglandin J2. 2006 J. Neuroimmunol. pmid:16225932
Zhao ML et al. 15-deoxy-delta (12,14)-PGJ2 inhibits astrocyte IL-1 signaling: inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. 2004 J. Neuroimmunol. pmid:15265671
Sutarmo Setiadji V et al. Actions of prostaglandin E2 on rat supraoptic neurones. 1998 J. Neuroendocrinol. pmid:9870750
Kitanaka J et al. Phloretin as an antagonist of prostaglandin F2 alpha receptor in cultured rat astrocytes. 1993 J. Neurochem. pmid:8093482
Haskew-Layton RE et al. 15-Deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) protects neurons from oxidative death via an Nrf2 astrocyte-specific mechanism independent of PPARγ. 2013 J. Neurochem. pmid:23199167
Hosoi T et al. Possible involvement of 15-deoxy-Δ(12,14) -prostaglandin J2 in the development of leptin resistance. 2015 J. Neurochem. pmid:25662180
Satoh T et al. Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins. 2001 J. Neurochem. pmid:11279261
Fiebich BL et al. Prostaglandin E2 induces interleukin-6 synthesis in human astrocytoma cells. 1997 J. Neurochem. pmid:9003059
Fujimori K et al. Prevention of paraquat-induced apoptosis in human neuronal SH-SY5Y cells by lipocalin-type prostaglandin D synthase. 2012 J. Neurochem. pmid:22043816
Zander T et al. Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. 2002 J. Neurochem. pmid:12065618
Yagami T et al. Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. 2002 J. Neurochem. pmid:12065654
Vesin MF et al. Preferential synthesis of prostaglandin D2 by neurons and prostaglandin E2 by fibroblasts and nonneuronal cells in chick dorsal root ganglia. 1991 J. Neurochem. pmid:2051162
Hatanaka M et al. Late-phase accumulation of inositol phosphates stimulated by prostaglandins D2 and F2 alpha in neuroblastoma x glioma hybrid NG108-15 cells. 1989 J. Neurochem. pmid:2507741
Liang X et al. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. 2005 J. Neurochem. pmid:15659218
Huang W et al. PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells. 2008 J. Neurochem. pmid:18710415
Ajmone-Cat MA et al. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. 2003 J. Neurochem. pmid:14622099
Phulwani NK et al. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway. 2006 J. Neurochem. pmid:17074064
Oda A et al. Characterization of ovolin, an orally active tryptic peptide released from ovalbumin with anxiolytic-like activity. 2012 J. Neurochem. pmid:22564055
Grill M et al. Effect of endotoxin treatment on the expression and localization of spinal cyclooxygenase, prostaglandin synthases, and PGD2 receptors. 2008 J. Neurochem. pmid:18028337
Terao A et al. Roles of prostaglandins D2 and E2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. 1995 J. Neurochem. pmid:7595573
Arnaud LT et al. Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells. 2009 J. Neurochem. pmid:19457109
Bernardo A et al. 15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms. 2003 J. Neurochem. pmid:14535956
Kielian T et al. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2). 2004 J. Neurochem. pmid:15312171
Vesin MF and Droz B Biosynthesis of prostaglandins D2 and E2 in chick dorsal root ganglion during development. 1991 J. Neurochem. pmid:1904909
Wolfe LS et al. Metabolism of prostaglandin D2 by human cerebral cortex into 9 alpha, 11 beta-prostaglandin F2 by an active NADPH-dependent 11-ketoreductase. 1989 J. Neurochem. pmid:2723663
Saito Y et al. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. 2007 J. Neurochem. pmid:17697048
Terao A et al. Gene expression in the rat brain during prostaglandin D2 and adenosinergically-induced sleep. 2008 J. Neurochem. pmid:18331290
Gebicke-Haerter PJ et al. Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. 1991 J. Neurochem. pmid:1828830
Ogorochi T et al. Regional distribution of prostaglandins D2, E2, and F2 alpha and related enzymes in postmortem human brain. 1984 J. Neurochem. pmid:6427411
Ueno R et al. Changes of enzymes involved in prostaglandin metabolism and prostaglandin binding proteins in rat brain during development and aging. 1985 J. Neurochem. pmid:3925085
Marriott DR et al. Substance P-induced release of prostaglandins from astrocytes: regional specialisation and correlation with phosphoinositol metabolism. 1991 J. Neurochem. pmid:1702831
Miwa N et al. Prostaglandin induces Ca2+ influx and cyclic GMP formation in mouse neuroblastoma X rat glioma hybrid NG108-15 cells in culture. 1988 J. Neurochem. pmid:2834513
Fiebich BL et al. Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease. 1998 J. Neural Transm. Suppl. pmid:9850935
Abraki SB et al. Simultaneous inhibition of COX-2 and activation of PPAR-γ resulted in the same level and pattern of neuroprotection as they were targeted separately. 2013 J. Mol. Neurosci. pmid:23132402
Vishwakarma P et al. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis. 2016 J. Mol. Med. pmid:26830627
Waku T et al. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids. 2009 J. Mol. Biol. pmid:18977231
Perbandt M et al. Structure of the extracellular glutathione S-transferase OvGST1 from the human pathogenic parasite Onchocerca volvulus. 2008 J. Mol. Biol. pmid:18258257
Kim HY et al. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages. 2008 J. Microbiol. Biotechnol. pmid:18600064
Luker T et al. Zwitterionic CRTh2 antagonists. 2011 J. Med. Chem. pmid:21355602
Crosignani S et al. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases. 2011 J. Med. Chem. pmid:21916510
Armer RE et al. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2. 2005 J. Med. Chem. pmid:16190744
Tsuri T et al. Bicyclo[2.2.1]heptane and 6,6-dimethylbicyclo[3.1.1]heptane derivatives: orally active, potent, and selective prostaglandin D2 receptor antagonists. 1997 J. Med. Chem. pmid:9357516
Takasuka M et al. FTIR spectral study of intramolecular hydrogen bonding in thromboxane A2 receptor agonist (U-46619), prostaglandin (PG)E2, PGD2, PGF2 alpha, prostacyclin receptor agonist (carbacyclin), and their related compounds in dilute CCl4 solution: structure-activity relationships. 1994 J. Med. Chem. pmid:8289201
Mitsumori S et al. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2.2.1]heptane derivatives. 2003 J. Med. Chem. pmid:12773047
Mitsumori S et al. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane derivatives. 2003 J. Med. Chem. pmid:12773048
Shiozaki M et al. Synthesis of 2-deoxy-2-[(2,2-difluoro-3-hydroxytetradecanoyl)amino]-3-O- [(R)-3-(tetradecanoyloxy)tetradecanoyl]-D-glucopyranose 4-phosphate. 1991 J. Med. Chem. pmid:1875354
Aldrovandi M et al. Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation. 2013 J. Lipid Res. pmid:23883581
Subra C et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. 2010 J. Lipid Res. pmid:20424270
Feng J et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. 2000 J. Lipid Res. pmid:10787429
Dichlberger A et al. Adipose triglyceride lipase regulates eicosanoid production in activated human mast cells. 2014 J. Lipid Res. pmid:25114172
Björnsson OG et al. Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism. 1992 J. Lipid Res. pmid:1331281
Kanai Y et al. Identification of novel oxidized levuglandin D2 in marine red alga and mouse tissue. 2011 J. Lipid Res. pmid:21893678
Hardy KD et al. Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo. 2011 J. Lipid Res. pmid:20944061
Farias SE et al. Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain. 2008 J. Lipid Res. pmid:18503030
Springstead JR et al. Evidence for the importance of OxPAPC interaction with cysteines in regulating endothelial cell function. 2012 J. Lipid Res. pmid:22550136
Martínez B et al. The mitochondrial respiratory complex I is a target for 15-deoxy-delta12,14-prostaglandin J2 action. 2005 J. Lipid Res. pmid:15654126
Clay CE et al. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. 2002 J. Lipid Res. pmid:12401880
Ramer R et al. Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib. 2013 J. Lipid Res. pmid:23943857
Raetz CR et al. Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. 2006 J. Lipid Res. pmid:16479018
Schröder O et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells. 2006 J. Lipid Res. pmid:16495511
Blancou P and Anegon I Editorial: Heme oxygenase-1 and dendritic cells: what else? 2010 J. Leukoc. Biol. pmid:20123679
Guyton K et al. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. 2001 J. Leukoc. Biol. pmid:11310850
Noguchi J et al. Strain difference of murine bone marrow-derived mast cell functions. 2005 J. Leukoc. Biol. pmid:16126842
Alba G et al. Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils. 2008 J. Leukoc. Biol. pmid:18515325
Brown JR et al. Diminished production of anti-inflammatory mediators during neutrophil apoptosis and macrophage phagocytosis in chronic granulomatous disease (CGD). 2003 J. Leukoc. Biol. pmid:12714573
Tautenhahn A et al. Activation-induced PPARgamma expression sensitizes primary human T cells toward apoptosis. 2003 J. Leukoc. Biol. pmid:12714582
Biburger M et al. Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity. 2010 J. Leukoc. Biol. pmid:19797297
Sandig H et al. Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. 2007 J. Leukoc. Biol. pmid:17043246
Khan E and Abu-Amer Y Activation of peroxisome proliferator-activated receptor-gamma inhibits differentiation of preosteoblasts. 2003 J. Lab. Clin. Med. pmid:12878983
Bertelé V et al. Refractoriness of platelets to prostaglandins after infusion in rabbits. 1985 J. Lab. Clin. Med. pmid:2997353
Lifschitz MD Renal effects of nonsteroidal anti-inflammatory agents. 1983 J. Lab. Clin. Med. pmid:6411840
De Oliveira C et al. Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells. 2005 J. Lab. Clin. Med. pmid:15871306
Lee JH et al. 15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes. 2007 J. Korean Med. Sci. pmid:17982241
Yoon EK et al. ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. 2007 J. Korean Med. Sci. pmid:18162716
Clay CE et al. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. 2001 J. Investig. Med. pmid:11523697
Kaur S et al. Induction of prostaglandin D2 through the p38 MAPK pathway is responsible for the antipruritic activity of sertaconazole nitrate. 2010 J. Invest. Dermatol. pmid:20505747
Burrall B and Ziboh VA Increased biosynthesis of lipoxygenase products by UVB-irradiated guinea pig epidermis: evidence of a cyclooxygenase inhibitor. 1986 J. Invest. Dermatol. pmid:3086462
Kuwamoto K et al. Possible involvement of enhanced prostaglandin E2 production in the photosensitivity in xeroderma pigmentosum group A model mice. 2000 J. Invest. Dermatol. pmid:10651981
Roberts LJ and Oates JA Biochemical diagnosis of systemic mast cell disorders. 1991 J. Invest. Dermatol. pmid:16799604
Nelson AM et al. Prostaglandin D2 inhibits wound-induced hair follicle neogenesis through the receptor, Gpr44. 2013 J. Invest. Dermatol. pmid:23190891
Stellato C et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1373749
Morrow JD et al. Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. 1992 J. Invest. Dermatol. pmid:1373750
Ikai K et al. Induction of 72-kD heat shock protein and cytoskeleton damage by cytotoxic prostaglandin delta 12-PGJ2 in transformed human epidermal cells in culture. 1992 J. Invest. Dermatol. pmid:1375619
de Paulis A et al. Anti-inflammatory effect of FK-506 on human skin mast cells. 1992 J. Invest. Dermatol. pmid:1281861
Kozuka T et al. Prostaglandin D2 release by guinea pig skin during in vitro anaphylaxis induced by antigen and compound 48/80. 1987 J. Invest. Dermatol. pmid:2433354
Maciejewski-Lenoir D et al. Langerhans cells release prostaglandin D2 in response to nicotinic acid. 2006 J. Invest. Dermatol. pmid:17008871
Hawk JL et al. Increased concentrations of arachidonic acid, prostaglandins E2, D2, and 6-oxo-F1 alpha, and histamine in human skin following UVA irradiation. 1983 J. Invest. Dermatol. pmid:6343514
Furukawa F et al. Relationship between heat shock protein induction and the binding of antibodies to the extractable nuclear antigens on cultured human keratinocytes. 1993 J. Invest. Dermatol. pmid:8345220
Iinuma K et al. Involvement of Propionibacterium acnes in the augmentation of lipogenesis in hamster sebaceous glands in vivo and in vitro. 2009 J. Invest. Dermatol. pmid:19282842
Mössner R et al. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma. 2002 J. Invest. Dermatol. pmid:12230498
Iwasaki M et al. Association of a new-type prostaglandin D2 receptor CRTH2 with circulating T helper 2 cells in patients with atopic dermatitis. 2002 J. Invest. Dermatol. pmid:12230502
Mantel A et al. Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis. 2012 J. Invest. Dermatol. pmid:22170488
Maurice PD et al. The effect of prostaglandin D2 on the response of human skin to histamine. 1987 J. Invest. Dermatol. pmid:3476674
Grewe M et al. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. 1995 J. Invest. Dermatol. pmid:7798637
Zhang C et al. The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cells. 2004 J. Invest. Dermatol. pmid:15245439
Bull HA et al. Basophil mediator release in atopic dermatitis. 1993 J. Invest. Dermatol. pmid:7680056